Related references
Note: Only part of the references are listed.CircRNA: a rising star in gastric cancer
Rong Li et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Circular RNA circ-RanGAP1 regulates VEGFA expression by targeting miR-877-3p to facilitate gastric cancer invasion and metastasis
Jun Lu et al.
CANCER LETTERS (2020)
Recent Developments of Systemic Chemotherapy for Gastric Cancer
Hiroyuki Arai et al.
CANCERS (2020)
Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p/HUR/VEGF axis and suppressing HSP90 degradation
Mengyan Xie et al.
MOLECULAR CANCER (2020)
The Landscape of Circular RNA in Cancer
Josh N. Vo et al.
CELL (2019)
The circRNA-microRNA code: emerging implications for cancer diagnosis and treatment
Lorena Verduci et al.
MOLECULAR ONCOLOGY (2019)
Targeting ERK1/2 protein-serine/threonine kinases in human cancers
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2019)
A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by competing with active phosphoinositide-dependent Kinase-1
Xin Xia et al.
MOLECULAR CANCER (2019)
Circular RNA circNHSL1 promotes gastric cancer progression through the miR-1306-3p/SIX1/vimentin axis
Zhonglin Zhu et al.
MOLECULAR CANCER (2019)
The biogenesis, biology and characterization of circular RNAs
Lasse S. Kristensen et al.
NATURE REVIEWS GENETICS (2019)
circHECTD1 facilitates glutaminolysis to promote gastric cancer progression by targeting miR-1256 and activating β-catenin/c-Myc signaling
Juan Cai et al.
CELL DEATH & DISEASE (2019)
Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation
Feng Yang et al.
MOLECULAR CANCER (2019)
Circular RNA circAGO2 drives cancer progression through facilitating HuR-repressed functions of AGO2-miRNA complexes
Yajun Chen et al.
CELL DEATH AND DIFFERENTIATION (2019)
Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
Steve Wagner et al.
ONCOGENE (2019)
Translation of the circular RNA circ-catenin promotes liver cancer cell growth through activation of the Wnt pathway
Wei-Cheng Liang et al.
GENOME BIOLOGY (2019)
Circular RNAs in cancer: opportunities and challenges in the field
L. S. Kristensen et al.
ONCOGENE (2018)
A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis
Maolei Zhang et al.
ONCOGENE (2018)
Circular RNA and its mechanisms in disease: From the bench to the clinic
Bing Han et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Translation of CircRNAs
Nagarjuna Reddy Pamudurti et al.
MOLECULAR CELL (2017)
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
Hezhe Lu et al.
NATURE (2017)
Identifying and Characterizing circRNA-Protein Interaction
William W. Du et al.
THERANOSTICS (2017)
MEK Inhibitors in the Treatment of Metastatic Melanoma and Solid Tumors
Antonio M. Grimaldi et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2017)
Molecular classification of gastric cancer
N. -Y. Chia et al.
ANNALS OF ONCOLOGY (2016)
NON-CODING RNAs IN DEVELOPMENT AND DISEASE: BACKGROUND, MECHANISMS, AND THERAPEUTIC APPROACHES
Julia Beermann et al.
PHYSIOLOGICAL REVIEWS (2016)
Circular RNA Expression: Its Potential Regulation and Function
Julia Salzman
TRENDS IN GENETICS (2016)
Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis
Yu Sun et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2015)
Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention
Parisa Karimi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
circRNA Biogenesis Competes with Pre-mRNA Splicing
Reut Ashwal-Fluss et al.
MOLECULAR CELL (2014)
MAP kinase signalling cascades and transcriptional regulation
Shen-Hsi Yang et al.
GENE (2013)
Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors
Erick J. Morris et al.
CANCER DISCOVERY (2013)
MEK1/2 dual-specificity protein kinases: Structure and regulation
Robert Roskoski
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches
Antonella De Luca et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
ERK1/2 MAP kinases: Structure, function, and regulation
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2012)
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
Linda S. Steelman et al.
AGING-US (2011)
RAF protein-serine/threonine kinases: Structure and regulation
Robert Roskoski
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Targeting the RAF-MEK-ERK pathway in cancer therapy
Clara Montagut et al.
CANCER LETTERS (2009)
Targeting protein kinases in central nervous system disorders
Laura K. Chico et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets
Anthony J. Muslin
CLINICAL SCIENCE (2008)
The MAPK signalling pathways and colorectal cancer
JY Fang et al.
LANCET ONCOLOGY (2005)
Share Paper
